BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31631496)

  • 21. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*.
    Safdar N; O'Horo JC; Ghufran A; Bearden A; Didier ME; Chateau D; Maki DG
    Crit Care Med; 2014 Jul; 42(7):1703-13. PubMed ID: 24674924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
    Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
    Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dressing and securement for central venous access devices (CVADs): A Cochrane systematic review.
    Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
    Int J Nurs Stud; 2016 Jul; 59():177-96. PubMed ID: 27222463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.
    Ruschulte H; Franke M; Gastmeier P; Zenz S; Mahr KH; Buchholz S; Hertenstein B; Hecker H; Piepenbrock S
    Ann Hematol; 2009 Mar; 88(3):267-72. PubMed ID: 18679683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlorhexidine 2% and choice of transparent dressing increase skin reactions at central venous catheter insertion sites.
    Loewenthal M; Dobson P; Boyle M
    Am J Infect Control; 2016 Dec; 44(12):1712-1714. PubMed ID: 27544790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating central venous catheter care in a pediatric intensive care unit.
    Hatler C; Buckwald L; Salas-Allison Z; Murphy-Taylor C
    Am J Crit Care; 2009 Nov; 18(6):514-20; quiz 521. PubMed ID: 19880953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability.
    Montecalvo MA; McKenna D; Yarrish R; Mack L; Maguire G; Haas J; DeLorenzo L; Dellarocco N; Savatteri B; Rosenthal A; Watson A; Spicehandler D; Shi Q; Visintainer P; Wormser GP
    Am J Med; 2012 May; 125(5):505-11. PubMed ID: 22482848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimising central line-associated bloodstream infection rate in inserting central venous catheters in the adult intensive care units.
    Hina HR; McDowell JRS
    J Clin Nurs; 2017 Dec; 26(23-24):3962-3973. PubMed ID: 28334482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter-related infections than routinely used chlorhexidine gluconate solutions: A pilot multicenter randomized trial (ISRCTN2657745)?
    McCann M; Fitzpatrick F; Mellotte G; Clarke M
    Am J Infect Control; 2016 Aug; 44(8):948-9. PubMed ID: 27079247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
    Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
    BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections.
    Crawford AG; Fuhr JP; Rao B
    Infect Control Hosp Epidemiol; 2004 Aug; 25(8):668-74. PubMed ID: 15357159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
    Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
    Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
    Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
    Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
    Schwebel C; Lucet JC; Vesin A; Arrault X; Calvino-Gunther S; Bouadma L; Timsit JF
    Crit Care Med; 2012 Jan; 40(1):11-7. PubMed ID: 21926570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of hospital-acquired bloodstream infections through chlorhexidine gluconate-impregnated washcloth bathing in intensive care units: a systematic review and meta-analysis of randomised crossover trials.
    Afonso E; Blot K; Blot S
    Euro Surveill; 2016 Nov; 21(46):. PubMed ID: 27918269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing.
    Scheithauer S; Lewalter K; Schröder J; Koch A; Häfner H; Krizanovic V; Nowicki K; Hilgers RD; Lemmen SW
    Infection; 2014 Feb; 42(1):155-9. PubMed ID: 23934685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorhexidine and gauze and tape dressings for central venous catheters: a randomized clinical trial.
    Pedrolo E; Danski MT; Vayego SA
    Rev Lat Am Enfermagem; 2014 Oct; 22(5):764-71. PubMed ID: 25493671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
    Eggimann P; Pagani JL; Dupuis-Lozeron E; Ms BE; Thévenin MJ; Joseph C; Revelly JP; Que YA
    Intensive Care Med; 2019 Jun; 45(6):823-833. PubMed ID: 30997542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.